Print  Email
Late-Breaking Clinical Trials I

Monday, Nov. 13, 10:45 a.m.-12:05 p.m.
McCormick Place, Hall B

 

Invited Moderator 

Robert H. Eckel, Denver, Colo.

 

Invited Moderator 

Steven E. Nissen, Cleveland, Ohio  

10:45

FAME (The Federal Study of Adherence to Medications in the Elderly): A Randomized Controlled Trial on the Impact of a Medication Adherence Program on Control of Lipids and Blood Pressure 

Allen Taylor, Washington, D.C. 

11

Discussant 

Harlan M. Krumholz, New Haven, Conn.  

11:05

Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) Study Program: Cardiovascular Outcomes Following Long-term Treatment with Etoricoxib versus Diclofenac in Patients with Osteoarthritis and Rheumatoid Arthritis 

Christopher P. Cannon, Boston, Mass.  

11:20

Discussant 

Garett FitzGerald, Philadelphia, Pa.  

11:25

Effects of Pioglitazone Compared to Glimepiride on Carotid Intima-Media Thickness (CIMT) in Type 2 Diabetes - Results of the CHICAGO Study 

Theodore Mazzone, Chicago, Ill.  

11:40

Discussant 

Peter Wilson , Atlanta, Ga.  

11:45

A Randomized Trial of Folic Acid and B-Vitamins in the Secondary Prevention of Cardiovascular Events in Women: Results from the Women’s Antioxidant and Folic Acid Cardiovascular Study (WAFACS) 

Christine Albert, Boston, Mass.  

12

Discussant 

Rita F. Redberg, San Francisco, Calif.